Single-agent 5-azacytidine as post-transplant maintenance in high-risk myeloid malignancies undergoing allogeneic hematopoietic cell transplantation
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00277-022-04821-y.pdf
Reference52 articles.
1. Horowitz M, Schreiber H, Elder A et al (2018) Epidemiology and biology of relapse after stem cell transplantation. Bone Marrow Transplant 53:1379–1389. https://doi.org/10.1038/s41409-018-0171-z
2. Schmid C, Labopin M, Nagler A et al (2012) Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation. Blood 119:1599–1606. https://doi.org/10.1182/blood-2011-08-375840
3. Caulier A, Drumez E, Gauthier J et al (2019) Scoring system based on post-transplant complications in patients after allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: a study from the SFGM-TC. Curr Res Transl Med 67:8–15. https://doi.org/10.1016/j.retram.2018.08.003
4. Oran B, Giralt S, Couriel D et al (2007) Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation. Leukemia 21:2540–2544. https://doi.org/10.1038/sj.leu.2404828
5. Bazarbachi A, Schmid C, Labopin M et al (2020) Evaluation of trends and prognosis over time in patients with AML relapsing after allogeneic hematopoietic cell transplant reveals improved survival for young patients in recent years. Clin Cancer Res Off J Am Assoc Cancer Res 26:6475–6482. https://doi.org/10.1158/1078-0432.CCR-20-3134
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Stratégies préventives et thérapeutiques de la rechute après allogreffe de cellules souches hématopoïétiques pour les LAM pédiatriques (SFGM-TC);Bulletin du Cancer;2024-06
2. Comparative analysis of hypomethylating agents as maintenance therapy after allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia;Leukemia & Lymphoma;2023-09-21
3. Measurable residual disease in patients undergoing allogeneic transplant for acute myeloid leukemia;Best Practice & Research Clinical Haematology;2023-06
4. Overcoming relapse: prophylactic or pre-emptive use of azacitidine or FLT3 inhibitors after allogeneic transplantation for AML or MDS;International Journal of Hematology;2023-04-10
5. Commentary: Maintenance with hypomethylating agents after allogeneic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndrome: A systematic review and meta-analysis;Frontiers in Medicine;2022-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3